Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sabra Health Care REITSBRA +0.62%85 EV-to-EBITDA is 19.83 as of Aug. 08, 2026, which is 21% above its 10-year median of 16.43. GuruFocus rates SBRA with a GF Score™ of 85/100 and a GF Value™ of $20.35 (Fairly Valued). The stock has 12 warning signs investors should review. Among 671 REITs companies, Sabra Health Care REIT ranks worse than 69% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sabra Health Care REIT's enterprise value is $7,790.3 Mil.
Sabra Health Care REIT's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $392.8 Mil. Therefore, Sabra Health Care REIT's EV-to-EBITDA for today is 19.83.
The historical rank and industry rank for Sabra Health Care REIT's EV-to-EBITDA or its related term are showing as below:
SBRA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.51 Med: 16.43 Max: 34.01
Current: 19.83
During the past 13 years, the highest EV-to-EBITDA of Sabra Health Care REIT was 34.01. The lowest was 8.51. And the median was 16.43.
SBRA's EV-to-EBITDA is ranked worse than 69% of 671
companies
in the REITs industry
Industry Median: 15.53
vs SBRA: 19.83
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Sabra Health Care REIT (NAS:SBRA) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sabra Health Care REIT's PE Ratio (TTM) for today is calculated as:
Sabra Health Care REIT's share price for today is $21.04.
Sabra Health Care REIT's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.260.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sabra Health Care REIT EV-to-EBITDA vs REITs Industry
For the REITs industry and Real Estate sector, Sabra Health Care REIT's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sabra Health Care REIT's EV-to-EBITDA falls into.
Sabra Health Care REIT's current Enterprise Value is $7,790.3 Mil.
Sabra Health Care REIT's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $392.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sabra Health Care REIT (SBRA) has a EV-to-EBITDA of 19.83 as of Aug. 08, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sabra Health Care REIT. This is 21% above median its historical median of 16.43. Over the past decade, Sabra Health Care REIT's EV-to-EBITDA has ranged from 8.51 to 34.01. According to the industry distribution chart, Sabra Health Care REIT ranks #463 out of 671 companies in the REITs industry, placing it in the top 69%.
Is Sabra Health Care REIT's EV-to-EBITDA too high?
Sabra Health Care REIT's current EV-to-EBITDA of 19.83 is 21% above median its 10-year median of 16.43. Over the past 10 years, this metric has ranged from a low of 8.51 to a high of 34.01. The REITs industry median EV-to-EBITDA is 15.53. Sabra Health Care REIT's value of 19.83 is 27.7% above this industry median. Based on the distribution chart, Sabra Health Care REIT ranks #463 out of 671 companies in the REITs industry, which is below the industry midpoint. Overall, Sabra Health Care REIT has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's EV-to-EBITDA compare to NHI and HR?
According to the REITs industry distribution chart, Sabra Health Care REIT ranks #463 out of 671 companies for EV-to-EBITDA. This places Sabra Health Care REIT in the lower half of its industry. The industry median EV-to-EBITDA is 15.53. Sabra Health Care REIT's value of 19.83 is 27.7% above this benchmark. Historically, Sabra Health Care REIT's own EV-to-EBITDA has ranged from 8.51 to 34.01 over the past decade. While the company's 10-year median is 16.43 vs. the industry median of 15.53, Sabra Health Care REIT has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a REITs company?
The median EV-to-EBITDA among REITs companies is 15.53, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sabra Health Care REIT's current EV-to-EBITDA of 19.83 is 27.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sabra Health Care REIT. For the REITs industry, the median EV-to-EBITDA is 15.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sabra Health Care REIT's current EV-to-EBITDA is 19.83, which is 21% above median its own 10-year median of 16.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Based on GuruFocus' analysis, Sabra Health Care REIT (SBRA) is currently considered Fairly Valued. The stock's GF Value™ is $20.35, compared to a current price of $21.04 — trading 3.4% above its estimated fair value. The current EV-to-EBITDA is 19.83, which is 21% above median its 10-year median of 16.43 and 27.7% above the REITs industry median of 15.53. Sabra Health Care REIT's overall GF Score™ is 85/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Sabra Health Care REIT (SBRA), the current EV-to-EBITDA is 19.83 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sabra Health Care REIT (SBRA) Overvalued in 2026?
Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be overvalued.
The current stock price of $21.04 is trading 3.4% above its estimated GF Value™ of $20.35.
GuruFocus considers Sabra Health Care REIT to be Fairly Valued.
Key valuation signals for SBRA:
EV-to-EBITDA: 19.83 (21% above median its 10-year median of 16.43)
GF Value™: $20.35 vs. price of $21.04 (3.4% above fair value)
Industry Position: 27.7% above the REITs median (#463 of 671)
No single metric tells the full story. See the SBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
85GF Score
Get the complete analysis for SBRA
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SBRA has been successfully added to your 
